ar-c239 has been researched along with nan 190 in 1 studies
| Studies (ar-c239) | Trials (ar-c239) | Recent Studies (post-2010) (ar-c239) | Studies (nan 190) | Trials (nan 190) | Recent Studies (post-2010) (nan 190) |
|---|---|---|---|---|---|
| 45 | 0 | 5 | 245 | 0 | 33 |
| Protein | Taxonomy | ar-c239 (IC50) | nan 190 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MY; Tsai, KC; Xia, L | 1 |
1 other study(ies) available for ar-c239 and nan 190
| Article | Year |
|---|---|
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |